|
| Identification |
| Molecular Structure |
 |
CAS No. |
863127-77-9 |
| Molecular Formula |
C22H26ClN7O2S.H2O |
| Molecular Weight |
506.02 |
| Name |
Dasatinib monohydrate |
| Synonymous |
N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide monohydrate |
| Properties |
| Melting Point |
N/A
|
| Safety & Transportation Information |
| Harzard Symbols |
|
| Hs code |
|
| Supplier Specification |
| Appearance |
|
| Purity |
|
| Packages |
|
| Productivity |
|
| Storage |
|
| Notes |
Dasatinib, also known as BMS-354825, use in patients with chronic myelogenous leukemia (CML) after imatinib treatment and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is also being
assessed for use in metastatic melanoma.
|
|
|
|